IL123247A0 - Assay for the diagnosis of dementia - Google Patents
Assay for the diagnosis of dementiaInfo
- Publication number
- IL123247A0 IL123247A0 IL12324796A IL12324796A IL123247A0 IL 123247 A0 IL123247 A0 IL 123247A0 IL 12324796 A IL12324796 A IL 12324796A IL 12324796 A IL12324796 A IL 12324796A IL 123247 A0 IL123247 A0 IL 123247A0
- Authority
- IL
- Israel
- Prior art keywords
- dementia
- platelet
- individual
- sample
- diagnosis
- Prior art date
Links
- 206010012289 Dementia Diseases 0.000 title abstract 3
- 238000003556 assay Methods 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 239000000523 sample Substances 0.000 abstract 3
- 208000005314 Multi-Infarct Dementia Diseases 0.000 abstract 2
- 201000004810 Vascular dementia Diseases 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000013068 control sample Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Eye Examination Apparatus (AREA)
- Oscillators With Electromechanical Resonators (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL11546595A IL115465A0 (en) | 1995-09-29 | 1995-09-29 | Assay for the diagnosis of dementia |
| PCT/IL1996/000118 WO1997013152A1 (en) | 1995-09-29 | 1996-09-26 | Assay for the diagnosis of dementia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL123247A0 true IL123247A0 (en) | 1998-09-24 |
Family
ID=11068036
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11546595A IL115465A0 (en) | 1995-09-29 | 1995-09-29 | Assay for the diagnosis of dementia |
| IL12324796A IL123247A0 (en) | 1995-09-29 | 1996-09-26 | Assay for the diagnosis of dementia |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11546595A IL115465A0 (en) | 1995-09-29 | 1995-09-29 | Assay for the diagnosis of dementia |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20030096227A1 (xx) |
| EP (1) | EP0856158B1 (xx) |
| AT (1) | ATE189742T1 (xx) |
| AU (1) | AU6999296A (xx) |
| CA (1) | CA2233321A1 (xx) |
| DE (1) | DE69606651T2 (xx) |
| IL (2) | IL115465A0 (xx) |
| WO (1) | WO1997013152A1 (xx) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL122490A0 (en) | 1997-12-07 | 1998-06-15 | Yeda Res & Dev | Assay for schizophrenia based on skin reaction |
| US20080107601A1 (en) * | 2004-10-13 | 2008-05-08 | Ablynx N.V. | Nanobodies Tm Against Amyloid-Beta and Polypeptides Comprising the Same for the Treatment of Degenerative Neural Diseases Such as Alzheimer's Disease |
| JP5097557B2 (ja) * | 2005-12-22 | 2012-12-12 | ローム株式会社 | 免疫測定装置及び方法 |
| US8460879B2 (en) | 2006-02-21 | 2013-06-11 | The Trustees Of Tufts College | Methods and arrays for target analyte detection and determination of target analyte concentration in solution |
| US11237171B2 (en) | 2006-02-21 | 2022-02-01 | Trustees Of Tufts College | Methods and arrays for target analyte detection and determination of target analyte concentration in solution |
| US9012237B2 (en) * | 2009-11-17 | 2015-04-21 | Servicios Cientificos Neuroinnovation Limitada | Innovative blood platelets biomarker for early diagnosis of alzheimer's disease |
| US9110025B2 (en) | 2010-03-01 | 2015-08-18 | Quanterix Corporation | Methods and systems for extending dynamic range in assays for the detection of molecules or particles |
| US8236574B2 (en) | 2010-03-01 | 2012-08-07 | Quanterix Corporation | Ultra-sensitive detection of molecules or particles using beads or other capture objects |
| US9952237B2 (en) | 2011-01-28 | 2018-04-24 | Quanterix Corporation | Systems, devices, and methods for ultra-sensitive detection of molecules or particles |
| US20140302532A1 (en) | 2011-04-12 | 2014-10-09 | Quanterix Corporation | Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury |
| WO2014113502A1 (en) | 2013-01-15 | 2014-07-24 | Quanterix Corporation | Detection of dna or rna using single molecule arrays and other techniques |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9007922D0 (en) * | 1990-04-07 | 1990-06-06 | Oxford Virology Plc | A diagnostic test method |
| WO1993010459A1 (en) * | 1991-11-12 | 1993-05-27 | The University Of Melbourne | A method for assaying and treating alzheimer's disease |
| IL107515A (en) * | 1993-11-05 | 1997-01-10 | Yeda Res & Dev | Diagnosis of mental disorders |
| EP0748447A4 (en) * | 1994-03-01 | 1998-11-18 | Yeda Res & Dev | TEST FOR DIAGNOSIS OF SCHIZOPHRENIA |
-
1995
- 1995-09-29 IL IL11546595A patent/IL115465A0/xx unknown
-
1996
- 1996-09-26 AU AU69992/96A patent/AU6999296A/en not_active Abandoned
- 1996-09-26 AT AT96931219T patent/ATE189742T1/de not_active IP Right Cessation
- 1996-09-26 EP EP96931219A patent/EP0856158B1/en not_active Expired - Lifetime
- 1996-09-26 CA CA002233321A patent/CA2233321A1/en not_active Abandoned
- 1996-09-26 WO PCT/IL1996/000118 patent/WO1997013152A1/en active IP Right Grant
- 1996-09-26 DE DE69606651T patent/DE69606651T2/de not_active Expired - Lifetime
- 1996-09-26 US US09/043,781 patent/US20030096227A1/en not_active Abandoned
- 1996-09-26 IL IL12324796A patent/IL123247A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE189742T1 (de) | 2000-02-15 |
| US20030096227A1 (en) | 2003-05-22 |
| DE69606651D1 (de) | 2000-03-16 |
| CA2233321A1 (en) | 1997-04-10 |
| IL115465A0 (en) | 1995-12-31 |
| AU6999296A (en) | 1997-04-28 |
| WO1997013152A1 (en) | 1997-04-10 |
| DE69606651T2 (de) | 2000-06-15 |
| EP0856158A1 (en) | 1998-08-05 |
| EP0856158B1 (en) | 2000-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE128183T1 (de) | Peptide und antikörper, die die bindung von blutplättchen verhindern. | |
| GB2294267B (en) | Anti-TNFalpha Fab fragments derived from polyclonal IgG antibodies | |
| IL123247A0 (en) | Assay for the diagnosis of dementia | |
| CY2618B2 (xx) | ||
| NO170128C (no) | Fremgangsmaate for dannelse av et monoklonalt antistoff for anvendelse som et diagnostisk posisjonsspesifikt reagens | |
| AR243931A1 (es) | Antigeno purificado,conjunto de reactivos para la deteccion de anticuerpos anti-hiv-2 en un fluido biologico que comprende dichos antigenos,anticuerpos,hibridomas y procedimientos. | |
| ATE163481T1 (de) | Charakterisierung von störungen der blutplättchenaggregation | |
| NO932320D0 (no) | Fremgangsmaate for paavisning av en analytt i en proeve og et utstyrsett for denne | |
| AU1370592A (en) | Immunoassay for detection of mutant p53 polypeptide in biological fluids | |
| DE69032112D1 (de) | Verfahren zur Isolierung von fetalen Zytotrophoblastzellen | |
| AU6828387A (en) | Assay for human breast cancer | |
| CN101981452A (zh) | 肺炎球菌检测方法 | |
| EP0311094A3 (de) | Diagnostisches Mittel und Verfahren zur Bestimmung von Apolipoprotein B | |
| FI883585A0 (fi) | Menetelmä verihiutalesolun pinta-antigeenin läsnäolon toteamiseksi | |
| CA2213083A1 (en) | Detection of antibody production | |
| ATE108553T1 (de) | Immuntestverfahren und reagenzsatz dazu. | |
| AU7407096A (en) | In vitro methods for determining in vivo thrombotic events | |
| CA2095410A1 (en) | Production and Characteristics of Anti-Teicoplanin Polyclonal Antibody | |
| AU1567688A (en) | Method for the quantitative determination of serum proteins in body fluids and agents for carrying out the process | |
| AU656198B2 (en) | Diagnostic method | |
| CA2175697A1 (en) | Diagnosis of mental disorders | |
| CA2081879A1 (en) | Monoclonal antibodies to polyacrylate polymers | |
| CA2239882A1 (en) | Method of determining or detecting donor organ damage following xenotransplantation based on donor organ-derived analytes | |
| AU8008487A (en) | A method for determining the presence of substances of diagnostic relevance, in particular antibodies or antigens, by the ELISA method with photometric evaluation | |
| BE899484A (fr) | Nouveaux determinants antigeniques apparentes a l'adenocarcinome et anticorps qui leur sont specifiques. |